spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PCI Pharma Services Announces Serialization Installation at Tredegar Manufacturing Center of Excellence

PCI’s Tredegar site is the latest site to offer full Serialization services to global customers

PCI Pharma Services (PCI) is pleased to announce the installation and validation of its latest comprehensive Serialization system, located at its manufacturing Center of Excellence in Tredegar, UK.  The investment demonstrates PCI’s continued investment in and expansion of market-leading Serialization capabilities. This latest installation increases PCI’s Serialization capability to support clients in advance of implementation dates for the European Falsified Medicines Directive (EU FMD), as well as supply for the US and emerging markets, including countries such as China, Turkey, Brazil, Saudi Arabia and others.  PCI’s system is compliant to all EU member country requirements for Serialization and specialized labeling, including application and integration of advanced Anticounterfeiting technologies.

 

The highly flexible technology delivers machine and human-readable coding, tamper evident solutions and Bollini labeling – which in turn is linked to a case loading and aggregation station, with a final aggregation station connecting cases to pallet. PCI is a strong supporter of the advanced use of aggregation to support product security, realizing the significant benefits in packaging operations, as well as the broader pharmaceutical supply chain.

 

PCI’s site in Tredegar, South Wales, UK already offers excellence in potent manufacturing services for customers globally, and this new Serialization technology further strengthens its comprehensive offering. This investment in the Tredegar facility is part of a significant global initiative to develop the Serialization services across PCI’s global network, which will ultimately exceed more than 90 lines.

 

Commenting on this latest investment, Jim Neville, Director of Operations, Tredegar, stated: “This is an important addition to the site’s capabilities. Being able to offer this fully flexible service and work in partnership with our customers to deliver a trusted, seamless service is critical, and being ahead of the timelines with this offering ensures compliance with the EU FMD.

 

PCI has been actively Serializing commercial products for the US, European and international markets for the past six years, and this investment in the Tredegar capabilities continues to demonstrate PCI’s market-leading position. The integrated technology strategy enables operators in all PCI’s global locations to operate the same graphical user interface, providing a seamless global service.  PCI clients enjoy singular connectivity to all PCI sites through a best-in-class platform.  PCI is dedicated to maintaining a leadership position at the forefront of the Serialization initiative and providing clients with an industry-leading customer experience.

 

To find out more about PCI, please visit www.pciservices.com

 

About PCI Pharma Services  

The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle — from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives.  For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.

 

 

Contact

 

Tom Gosschalk / Carrie Lowe at becg

tom.gosschalk@becg.com / carrie.lowe@becg.com             

 

T: +44 (0)203 697 7647 / +44 (0)1962 893 913

 
Print this page
Send to a friend
   
spacer
News and Press Releases

Temperature Controlled Logistics returns with a top schedule for 2019

The 18th annual Temperature Controlled Logistics Conference will bring together supply chain, logistics and quality experts from around the globe to experience four days of ‘unmissable’ workshops, case studies, panels, interactive discussion groups and technology showcases.
More info >>


White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

Industry Events

World Advanced Therapies & Regenerative Medicine Congress 2019

15-17 May 2019, Business Design Centre, London

The World Advanced Therapies & Regenerative Medicine Congress is an exhibition and conference that has grown to become one of the best and most established cell and gene events in the world today.     The 2019 edition will be in its 14th year and it continues to grow and attract a large audience of biotech, pharma, start-ups, investors, research and technology companies from around the world. The conference and exhibition will host over 1000 attendees, 250 speakers and 80 exhibition booths. Over 500 different global companies are represented every year at this event. 
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement